← BICYCLE THERAPEUTICS PLC

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $2.1m $7.1m $13.8m $10.4m $11.7m $14.5m $27.0m $35.3m $72.6m
Research and development $11.9m $20.8m $25.5m $33.1m $44.9m $81.6m $156.5m $173.0m $240.3m
Operating Expenses $18.3m $28.9m $40.1m $62.4m $77.3m $131.1m $216.9m $245.1m $319.7m
Total operating expenses $18.3m $28.9m $40.1m $62.4m $77.3m $131.1m $216.9m $245.1m $319.7m
Operating Income (Loss) ($16.2m) ($21.7m) ($26.3m) ($52.0m) ($65.6m) ($116.7m) ($189.9m) ($209.9m) ($247.1m)
Additional Financial Items
Foreign Currency Transaction Gain (Loss), before Tax — — — — — ($600k) ($600k) ($700k) $700k
Foreign Currency Transaction Gain (Loss), Realized — $300k $900k $600k $400k — — — —
Income (Loss) from Continuing Operations before Income Taxes, Domestic — ($13k) $1.0m $787k $1.1m $2.0m $3.8m $5.8m ($225.5m)
Interest and Other Income $50k $169k $814k $683k $120k $5.8m $14.0m $34.3m $28.5m
Collaboration revenue $2.1m $7.1m $13.8m $10.4m $11.7m $14.5m $27.0m $35.3m $72.6m
General and administrative $6.4m $8.1m $14.6m $29.2m $32.4m $49.5m $60.4m $72.2m $79.4m
Loss from operations ($16.2m) ($21.7m) ($26.3m) ($52.0m) ($65.6m) ($116.7m) ($189.9m) ($209.9m) ($247.1m)
Net loss before income tax provision ($16.3m) ($22.2m) ($30.9m) ($51.7m) ($68.5m) ($114.2m) ($179.2m) ($173.8m) ($218.8m)
Provision for (benefit from) income taxes ($23k) ($396k) ($254k) ($724k) ($1.7m) ($1.5m) $1.5m ($4.8m) $152k
Net loss ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Foreign currency translation adjustment $2.4m ($1.8m) $216k ($1.7m) ($195k) $3.8m ($1.7m) $1.4m ($3.6m)
Diluted EPS ($48.81) ($49.78) ($2.77) ($2.66) ($2.67) ($3.80) ($5.08) ($2.90) ($3.16)
Diluted NI Availto Com Stockholders ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Gain On Sale Of Security — — — — — ($555k) ($594k) ($719k) $653k
Interest Income $50k $169k $814k $683k $120k $5.8m $14.0m $34.3m $28.5m
Interest Income Non Operating $50k $169k $814k $683k $120k $5.8m $14.0m $34.3m $28.5m
Net Income From Continuing And Discontinued Operation ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Net Income From Continuing Operation Net Minority Interest ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Net Interest Income — — — — — $2.4m $10.7m $32.6m $28.3m
Normalized EBITDA — — — — — ($107.2m) ($169.4m) ($167.7m) ($212.8m)
Normalized Income — — — — — ($112.7m) ($180.7m) ($171.8m) ($219.4m)
Other Gand A — — — — — $49.5m $60.4m $29.3m $30.2m
Reconciled Depreciation — — — — — $3.7m $6.5m $7.2m $6.4m
Salaries And Wages — — — — — $30.3m $35.9m $42.2m $49.8m
Selling General And Administration — — — — — $49.5m $60.4m $71.5m $80.0m
Special Income Charges — — — — — $0 $0 $3.5m $0
Tax Effect Of Unusual Items — — — — — $0 $0 $77k $163k
Tax Provision ($23k) ($396k) ($254k) ($724k) ($1.7m) ($1.5m) $1.5m ($4.8m) $152k
Tax Rate For Calcs — — — — — $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($16.3m) ($22.2m) ($30.9m) ($51.7m) ($68.5m) ($114.2m) ($179.2m) ($173.8m) ($218.8m)
Total other income, net ($69k) ($496k) ($4.6m) $226k ($2.9m) $2.4m $10.7m $36.1m $28.3m
Total comprehensive loss ($13.9m) ($23.7m) ($30.4m) ($52.7m) ($67.0m) ($108.9m) ($182.4m) ($167.6m) ($222.6m)
Total Unusual Items — — — — — $0 $0 $2.8m $653k
Total Unusual Items Excluding Goodwill — — — — — $0 $0 $2.8m $653k
Pre-Tax Income ($16.3m) ($22.2m) ($30.9m) ($51.7m) ($68.5m) ($114.2m) ($179.2m) ($173.8m) ($218.8m)
Net Income Continuous Operations ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Net Income (Loss) Attributable to Parent ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Net Income (Loss) Available to Common Stockholders, Basic ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Net Income Including Noncontrolling Interests ($16.3m) ($21.8m) ($30.6m) ($51.0m) ($66.8m) ($112.7m) ($180.7m) ($169.0m) ($219.0m)
Earnings Per Share, Basic ($48.81) ($49.78) ($2.77) ($2.66) ($2.67) ($3.80) ($5.08) ($2.90) ($3.16)
Earnings Per Share, Diluted ($48.81) ($49.78) ($2.77) ($2.66) ($2.67) ($3.80) ($5.08) ($2.90) ($3.16)
Common Stock, Dividends, Per Share, Declared — — ($2.77) ($2.66) ($2.67) ($3.80) $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic — — 11.0m 19.1m 25.1m 29.7m 35.6m 58.2m 69.3m
Weighted average ordinary shares outstanding, basic (in shares) — — 11.0m 19.1m 25.1m 29.7m 35.6m 58.2m 69.3m
Weighted average ordinary shares outstanding, diluted (in shares) — — 11.0m 19.1m 25.1m 29.7m 35.6m 58.2m 69.3m
Basic Average Shares — — 11.0m 19.1m 25.1m $29.7m $35.6m $58.2m $69.3m
Diluted Average Shares — — 11.0m 19.1m 25.1m $29.7m $35.6m $58.2m $69.3m
Weighted Average Number of Shares Outstanding, Diluted — — 11.0m 19.1m 25.1m 29.7m 35.6m 58.2m 69.3m
Research and Development Expense $11.9m $20.8m $25.5m $33.1m $44.9m $81.6m $156.5m $173.0m $240.3m
General and Administrative Expense $6.4m $8.1m $14.6m $29.2m $32.4m $49.5m $60.4m $72.2m $79.4m
Other Nonoperating Income (Expense) — ($665k) ($5.4m) — — — — — —
Interest Expense (non-operating) — — — — — $3.3m $3.3m $1.7m $206k
Interest Expense — — — $457k $3.0m $3.3m $3.3m ($1.7m) ($206k)
Current Income Tax Expense (Benefit) — ($18k) $110k ($51k) $5k $3.5m ($1.8m) $461k $1.0m
Net Non Operating Interest Income Expense — — — — — $2.4m $10.7m $32.6m $28.3m
Operating Expense — — — — — $131.1m $216.9m $244.4m $320.3m
Other Income Expense — — — — — ($555k) ($594k) $2.8m $653k
Income Tax Expense (Benefit) ($23k) ($396k) ($254k) ($724k) ($1.7m) ($1.5m) $1.5m ($4.8m) $152k
Total Expenses — — — — — $131.1m $216.9m $244.4m $320.3m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.